HAIs

Latest News


Latest Videos


More News

Unmasking VIM Pseudomonas aeruginosa  (Adobe Stock 128549555)

VIM-producing Pseudomonas aeruginosa isn’t just surviving in ICUs; it’s thriving. With mortality rates exceeding 30%, colonization risks hiding in drains, devices, and even donor milk, IPs must take proactive steps to outsmart this pathogen. Now is the time to double down on environmental controls, risk factor recognition, and surveillance strategies. Let’s break the biofilm cycle before the next outbreak takes root.

A mother and child having online telemedicine consultation with remote doctor about cold and flu virus treatment.  (Adobe Stock 479767497 Studio Romantic)

In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.

Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste. (Adobe Stock 1521632893 by Maksim)

Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.

Realistic electron microscopy of Clostridioides difficile, highly detailed rod-shaped structure, spores with textured surfaces, flagella, acid-green and purple hues, contrasting black background.  (Adobe Stock 1318793046 by Waseem by AI)

A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.